National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/26/2021 release of VAERS data:

Found 4,760 cases where Vaccine is HPV2

Government Disclaimer on use of this data



Case Details

This is page 3 out of 476

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12   next


VAERS ID: 409925 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2010-11-19
Onset:2010-11-19
   Days after vaccination:0
Submitted: 2010-11-22
   Days after onset:3
Entered: 2010-11-23
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 2 RA / IM

Administered by: Private       Purchased by: Private
Symptoms: Back pain, Body temperature increased
SMQs:, Neuroleptic malignant syndrome (broad), Retroperitoneal fibrosis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Back pain, temp in 101.4.


VAERS ID: 409991 (history)  
Form: Version 1.0  
Age: 11.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2010-08-11
Onset:0000-00-00
Submitted: 2010-11-12
Entered: 2010-11-24
   Days after submission:12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS 0096Z / 1 UN / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR 1606Y / 1 UN / UN
TDAP: TDAP (ADACEL) / SANOFI PASTEUR C3789AA / 1 UN / UN
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. 1606Y / 2 UN / UN

Administered by: Private       Purchased by: Unknown
Symptoms: Dermatitis, Erythema, Oedema peripheral
SMQs:, Cardiac failure (broad), Anaphylactic reaction (broad), Angioedema (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: NKA
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: 08/13/10 swelling & redness of arm. Seen by PA at PCP office: Dx: "local dermatitis following varicella vaccine". Tx: PRELONE, cool compress prn & local hydrocortisone.


VAERS ID: 414506 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Male  
Location: Illinois  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2011-01-11
Entered: 2011-01-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS AHAVB446AA / 1 LA / IM
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 1 LA / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR U3468AA / 1 RA / IM

Administered by: Public       Purchased by: Public
Symptoms: Contraindication to vaccination, No adverse event
SMQs:, Medication errors (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: Shoulder pain
Preexisting Conditions: None known
Allergies:
Diagnostic Lab Data: None
CDC Split Type:

Write-up: CERVARIX given to male patient. No adverse/side effects reported from patient/parent.


VAERS ID: 415297 (history)  
Form: Version 1.0  
Age: 24.0  
Sex: Female  
Location: Virginia  
Vaccinated:2010-08-10
Onset:2010-11-07
   Days after vaccination:89
Submitted: 2011-01-24
   Days after onset:78
Entered: 2011-01-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 LA / UN

Administered by: Private       Purchased by: Other
Symptoms: Abortion spontaneous, Drug exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Multivitamin
Current Illness: Unknown
Preexisting Conditions: The subject had no relevant medical history and no history of adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: A0907909A

Write-up: This retrospective pregnancy case was reported by a consumer and described the occurrence of miscarriage in a 24-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline) while pregnant. A physician or other health care professional has not verified this report. Concurrent medications included Multivitamins. On 10 August 2010 at 11:00 the subject received 1st dose of CERVARIX in the left arm. The subject discovered she was pregnant one week later on 18 August 2010. The subject experienced vaccine exposure during pregnancy. The date of last menstrual period was not provided and her estimated date of delivery was 20 May 2011. On 7 November 2010, 89 days after vaccination with CERVARIX, the subject experienced a miscarriage. This case was assessed as medically serious by agency. No additional details were provided.


VAERS ID: 416997 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: South Carolina  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2011-02-07
Entered: 2011-02-10
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 AR / IJ

Administered by: Private       Purchased by: Private
Symptoms: Injection site erythema, Injection site swelling
SMQs:, Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Concomitant medications and relevant medical history were unknown. It was unknown whether the subject had experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: A0888733A

Write-up: This case was reported by a physician, via a GSK representative, and described the occurrence of swelling injection site in a female subject of unspecified age who was vaccinated with CERVARIX, (GlaxoSmithKline). On an unspecified date the subject received 1st dose of CERVARIX (unknown route, unknown arm). At an unspecified time after vaccination with CERVARIX, the subject experienced swelling injection site and injection site redness. The subject''s parent had reported an injection site reaction of large red circular swelling on their daughter''s arm following the 1st dose of CERVARIX. At the time of reporting the events were resolved. The physician considered the events were possibly related to vaccination with CERVARIX.


VAERS ID: 416998 (history)  
Form: Version 1.0  
Age: 12.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2010-11-20
Onset:2010-11-20
   Days after vaccination:0
Submitted: 2011-02-07
   Days after onset:79
Entered: 2011-02-10
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 AR / UN
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Private       Purchased by: Public
Symptoms: Accidental overdose, Dizziness, Wrong drug administered
SMQs:, Anticholinergic syndrome (broad), Drug abuse and dependence (broad), Vestibular disorders (broad), Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Concomitant medications and relevant medical history were unknown. It was unknown if adverse events occurred with previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: A0894703A

Write-up: This case was reported by a healthcare professional and described the occurrence of dizziness in a 12-year-old female subject who was vaccinated with CERVARIX, (GlaxoSmithKline), (non-gsk) GARDASIL. On 20 November 2010 the subject received 1st dose of CERVARIX (0.5 ml, unknown, unknown arm) and 1st dose of GARDASIL (unknown). On 20 November 2010, less than one day after vaccination with CERVARIX and GARDASIL, the subject experienced dizziness and unintentional overdose. The subject accidentally received CERVARIX and GARDASIL at the same time instead of CERVARIX and MENACTRA. She felt dizzy for 15 minutes but was fine after that. At the time of reporting the dizziness was resolved.


VAERS ID: 417001 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:2010-06-28
Onset:2010-06-28
   Days after vaccination:0
Submitted: 2011-02-07
   Days after onset:224
Entered: 2011-02-10
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 3 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Drug exposure during pregnancy, Weight increased
SMQs:, Hyperglycaemia/new onset diabetes mellitus (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: A0900670A

Write-up: This prospective pregnancy case was reported by a consumer and described the occurrence of weight gaining in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report during pregnancy. On 28 June 2010 the subject received 3rd dose of CERVARIX (unknown). Her last menstrual period was on an unspecified date and estimated date of delivery was on 11 March 2011. The subject was exposed to CERVARIX during the first trimester. On 28 June 2010 at the time of vaccination the subject experienced exposure during pregnancy; the subject found out she was pregnant on 04 July 2010. At an unspecified time after the subject received the 3rd dose of CERVARIX she experienced gaining weight. At the time of reporting the outcome of the gaining weight was unspecified and the pregnancy was ongoing. The reporter declined to provide contact information.


VAERS ID: 416689 (history)  
Form: Version 1.0  
Age: 23.0  
Sex: Female  
Location: Wisconsin  
Vaccinated:2011-02-11
Onset:2011-02-12
   Days after vaccination:1
Submitted: 2011-02-13
   Days after onset:1
Entered: 2011-02-14
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA092AD / 3 LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
SMQs:, Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ADDERALL
Current Illness: None
Preexisting Conditions: Fibromyalgia; Bipolar depression; Endometriosis; Dysmenorrhea
Allergies:
Diagnostic Lab Data: None
CDC Split Type:

Write-up: Localized swelling, redness, pain 5cm, (L) deltoid. Symptoms started day after vaccination received. Evaluated the day after that (Immunized Friday 2-11-11, eval 2-13-11).


VAERS ID: 418071 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: Indiana  
Vaccinated:2011-02-16
Onset:2011-02-18
   Days after vaccination:2
Submitted: 2011-03-04
   Days after onset:14
Entered: 2011-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA096AAD / 1 LG / UN

Administered by: Other       Purchased by: Public
Symptoms: Cold sweat, Condition aggravated, Drug administered at inappropriate site, Pruritus, Pyrexia, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Drug abuse and dependence (broad), Hypersensitivity (narrow), Medication errors (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No concurrent medication
Current Illness: skin allergy
Preexisting Conditions: Hive; The subject has "a lot of skin allergies"; reporter was unable to be specific. No adverse events were reported following receipt of prior immunizations.
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: A0916194A

Write-up: This case was reported by a healthcare professional and described the occurrence of hive in a 15-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included hive. Concurrent medical conditions included skin allergy. Previous and/or concurrent vaccination included GARDASIL (non-gsk); non-GSK manufacturer; unknown; unknown given on an unspecified date. There were no concurrent medications. On 16 February 2011 the subject received 1st dose of CERVARIX (.5 cc, unknown, unknown thigh) and experienced administered at inappropriate site. On 18 February 2011, 2 days after vaccination with CERVARIX, the subject experienced hive, itching. On 23 February 2011, 7 days after vaccination with CERVARIX, the subject experienced fever and cold sweat; the hives and itching fever continued. The 15-year old subject previously received three doses of GARDASIL two to three years ago. The reporter stated "that it was believed that a booster for HPV would be beneficial and given the CERVARIX data, that is the one they used". The subject received CERVARIX on 16 February 2011 and developed hives and itching on 18 February 2011. The subject was treated with antihistamines and cream. The hives and itching were getting better and on 23 February 2011, she developed a "major case of hives, itching, fever and cold sweats". The nurse, who is the mother of the subject, administered CERVARIX in the thigh at home (administered at inappropriate site). The subject has not previously had any reaction to vaccinations. It was noted that the subject "had hives before but nothing like this". The subject also "has a lot of skin allergies but specifics were no known" at the time of the report. The subject''s parents reviewed the two products GARDASIL and CERVARIX looking for ingredient differences that may have caused the reaction". The healthcare professional considered the events were clinically significant (or requiring intervention). At the time of reporting the hive, itching, fever and cold sweat were improved and "no serious issues reported in a while". The healthcare professional considered the events were possibly related to vaccination with CERVARIX.


VAERS ID: 418203 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Male  
Location: Iowa  
Vaccinated:2011-02-02
Onset:2011-02-02
   Days after vaccination:0
Submitted: 2011-03-08
   Days after onset:34
Entered: 2011-03-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHAPVA113AA / 1 AR / IM

Administered by: Private       Purchased by: Private
Symptoms: Drug administration error
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: no
Preexisting Conditions: no
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: none-misadministered


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=3&VAX=HPV2


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166